Cause of Death

• 

  Subject Areas on Research

  • "No one dies of old age": implications for research, practice, and policy. 
  • "Thin" malignant melanoma: risk factors and clinical management. 
  • 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. 
  • 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting. 
  • A comparison of operation, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography in biliary complications after hepatic transplantation. 
  • A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations. 
  • A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. 
  • A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. 
  • A risk score to predict bleeding in patients with acute coronary syndromes. 
  • A study on the diagnosis of drowning by examination of lung chlorophyll(a) of planktons with a spectrofluorophotometer. 
  • A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. 
  • Acute Heart Failure: Alternatives to Hospitalization. 
  • Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. 
  • Acute traumatic aortic aneurysm: the Duke experience from 1970 to 1990. 
  • Adenoid cystic carcinoma of the paranasal sinuses. 
  • Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. 
  • Advanced heart failure treated with continuous-flow left ventricular assist device. 
  • Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. 
  • Age-related macular degeneration and cancer mortality in the atherosclerosis risk in communities study. 
  • Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. 
  • Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. 
  • Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial. 
  • Albuminuria in chronic heart failure: prevalence and prognostic importance. 
  • Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • All-cause mortality risk associated with long-term exposure to ambient PM2·5 in China: a cohort study. 
  • Alternative models for the heterogeneity of mortality risks among the aged. 
  • American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). 
  • American Indian and Alaska Native infant and pediatric mortality, United States, 1999-2009. 
  • Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. 
  • Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. 
  • Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. 
  • Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality. 
  • Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • An In-Depth Examination of Reasons for Autopsy Acceptance and Refusal in Northern Tanzania. 
  • An alternative strategy for perinatal verbal autopsy coding: single versus multiple coders. 
  • An archival prospective study of mental health and longevity. 
  • An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome. 
  • Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. 
  • Animal, vegetable, or ... clinical trial? 
  • Antipsychotics and the risk of sudden cardiac death. 
  • Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. 
  • Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial. 
  • Asbestos standards: Impact of currently uncounted chrysotile asbestos fibers on lifetime lung cancer risk. 
  • Assessment of myocardial infarction by cardiac magnetic resonance imaging and long-term mortality. 
  • Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. 
  • Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. 
  • Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. 
  • Association Between Inferior Vena Cava Filter Insertion in Trauma Patients and In-Hospital and Overall Mortality. 
  • Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. 
  • Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. 
  • Association between bariatric surgery and long-term survival. 
  • Association between bilirubin and mode of death in severe systolic heart failure. 
  • Association between body mass index and mortality in patients with glioblastoma mutliforme. 
  • Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. 
  • Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry. 
  • Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial. 
  • Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure. 
  • Association of Balance Function With All-Cause and Cause-Specific Mortality Among US Adults. 
  • Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. 
  • Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals. 
  • Association of Early Stress Testing with Outcomes for Emergency Department Evaluation of Suspected Acute Coronary Syndrome. 
  • Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease. 
  • Association of Perioperative Plasma Neutrophil Gelatinase-Associated Lipocalin Levels with 3-Year Mortality after Cardiac Surgery: A Prospective Observational Cohort Study. 
  • Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement. 
  • Association of Restrictive Housing During Incarceration With Mortality After Release. 
  • Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement. 
  • Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction. 
  • Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network Registry. 
  • Association of an Early Intervention Service for Psychosis With Suicide Rate Among Patients With First-Episode Schizophrenia-Spectrum Disorders. 
  • Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. 
  • Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. 
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. 
  • Association of heat shock proteins with all-cause mortality. 
  • Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: a multicenter study. 
  • Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. 
  • Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients. 
  • Association of postdischarge complications with reoperation and mortality in general surgery. 
  • Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. 
  • Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. 
  • Association of the ankle-brachial index with history of myocardial infarction and stroke. 
  • Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures. 
  • Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction. 
  • Associations between published quality ratings of skilled nursing facilities and outcomes of medicare beneficiaries with heart failure. 
  • Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease. 
  • Associations of Accelerometry-Assessed and Self-Reported Physical Activity and Sedentary Behavior With All-Cause and Cardiovascular Mortality Among US Adults. 
  • Associations of Body Mass Index and Waist Circumference with 3-Year All-Cause Mortality Among the Oldest Old: Evidence from a Chinese Community-Based Prospective Cohort Study. 
  • Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. 
  • Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. 
  • Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. 
  • Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes. 
  • Atrial fibrillation and mortality risk: seeing the big picture. 
  • Autopsy validation study of the academic research consortium stent thrombosis definition. 
  • Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure. 
  • Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience. 
  • Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). 
  • Benefits of smoking cessation for longevity. 
  • Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial. 
  • Biologic hazards of double primary neoplasms among patients with genitourinary malignancy. 
  • Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. 
  • Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. 
  • Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality. 
  • Body mass index and nine-year mortality in disabled and nondisabled older U.S. individuals. 
  • Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. 
  • Brainstem dysfunction as a predictor of death in the nonneurologically injured. 
  • Canadian Task Force for Cardiovascular Science. A Joint Initiative of the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Society. 
  • Cancer and noncancer mortality among aluminum smelting workers in Badin, North Carolina. 
  • Cancer in the elderly. Epidemiologic and clinical implications. 
  • Cancer mortality, aging, and patterns of comorbidity in the United States: 1968 to 1986. 
  • Capability for suicide interacts with states of heightened arousal to predict death by suicide beyond the effects of depression and hopelessness. 
  • Cardiac computed tomographic angiography what's the prognosis? 
  • Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. 
  • Cardiac surgery in infants with low birth weight is associated with increased mortality: analysis of the Society of Thoracic Surgeons Congenital Heart Database. 
  • Cardiovascular mortality in twins and the fetal origins hypothesis. 
  • Cardiovascular screening in asymptomatic adults: lessons for the diving world. 
  • Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. 
  • Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. 
  • Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2. 
  • Cause, timing, and location of death in the Single Ventricle Reconstruction trial. 
  • Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial. 
  • Causes and timing of death in extremely premature infants from 2000 through 2011. 
  • Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart Disease. 
  • Causes of Death in Infants and Children with Congenital Heart Disease. 
  • Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial. 
  • Causes of Maternal Mortality in Rwanda, 2017-2019. 
  • Causes of community stillbirths and early neonatal deaths in low-income countries using verbal autopsy: an International, Multicenter Study. 
  • Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. 
  • Causes of death in long-term survivors of head and neck cancer. 
  • Causes of death in the Kasekela chimpanzees of Gombe National Park, Tanzania. 
  • Causes of death on antiretroviral therapy: a post-mortem study from South Africa. 
  • Causes of late mortality in pediatric liver transplant recipients. 
  • Causes of late mortality in pediatric liver transplant recipients. 
  • Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012. 
  • Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. 
  • Changes in health service use and mortality among U.S. elderly in 1980-1986. 
  • Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. 
  • Characterization of Death in Infants With Neonatal Seizures. 
  • Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study. 
  • Childhood conscientiousness and longevity: health behaviors and cause of death. 
  • Childhood psychopathology can be really bad for your health. 
  • Chlamydia pneumoniae and acute coronary syndrome. 
  • Chronic granulomatous disease. Report on a national registry of 368 patients. 
  • Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population. 
  • Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer. 
  • Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry. 
  • Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF. 
  • Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial. 
  • Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. 
  • Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease. 
  • Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. 
  • Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score. 
  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. 
  • Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. 
  • Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. 
  • Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. 
  • Clinical prediction models: are we building better mousetraps? 
  • Clinical predictors and outcome implications of early readmission in lung transplant recipients. 
  • Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. 
  • Co-morbidities Associated With Early Mortality in Adults With Spina Bifida. 
  • Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. 
  • Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. 
  • Commentary: Thank you, sir, may I TAVI another: Procedural problems and postoperative complications in SURTAVI. 
  • Common causes of open-circuit recreational diving fatalities. 
  • Common comorbidity scales were similar in their ability to predict health care costs and mortality. 
  • Comorbidity burden and nonclinical factors associated with sinonasal cancer all-cause mortality. 
  • Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients. 
  • Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials. 
  • Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee. 
  • Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout. 
  • Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART. 
  • Comparison of Long-Term Mortality of Patients Aged ≤40 Versus >40 Years With Acute Myocardial Infarction. 
  • Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction. 
  • Comparison of outcome after coronary angioplasty and coronary surgery for multivessel coronary artery disease in persons with diabetes. 
  • Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. 
  • Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes. 
  • Competing causes of death in the head and neck cancer population. 
  • Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. 
  • Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. 
  • Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. 
  • Concomitant changes in ventricular depolarization and repolarization and long-term outcomes of biventricular pacing. 
  • Concordance between administrative data and clinical review for mortality in the randomized on/off bypass follow-up study (ROOBY-FS). 
  • Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age. 
  • Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker. 
  • Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. 
  • Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study. 
  • Copy Number Variants of Undetermined Significance Are Not Associated with Worse Clinical Outcomes in Hypoplastic Left Heart Syndrome. 
  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture. 
  • Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. 
  • Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. 
  • Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. 
  • Cost-effectiveness of an injury and drowning prevention program in Bangladesh. 
  • Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. 
  • Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. 
  • Death and liver transplantation within 2 years of onset of drug-induced liver injury. 
  • Death in patients with permanent pacemakers for sick sinus syndrome. 
  • Death with an implantable cardioverter-defibrillator: a MADIT-II substudy. 
  • Deaths from external causes of injury among construction workers in North Carolina, 1988-1994. 
  • Deaths from gallstones. Incidence and associated clinical factors. 
  • Deaths from violence in North Carolina, 2004: how deaths differ in females and males. 
  • Deaths in childhood nephrotic syndrome in Ibadan, Nigeria. 
  • Declining Risk of Sudden Death in Heart Failure. 
  • Decreased cancer-independent life expectancy in the head and neck cancer population. 
  • Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. 
  • Depression as a risk factor for mortality after coronary artery bypass surgery. 
  • Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. 
  • Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury. 
  • Development and Validation of a Mortality Prediction Model for Patients Receiving 14 Days of Mechanical Ventilation. 
  • Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. 
  • Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial. 
  • Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405. 
  • Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION Trial. 
  • Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction. 
  • Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease. 
  • Digoxin and Mortality in Patients With Atrial Fibrillation. 
  • Discrimination: a new cardiovascular risk factor? 
  • Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. 
  • Do patients treated at academic hospitals have better longitudinal outcomes after admission for non-ST-elevation myocardial infarction? 
  • Does Despair Really Kill? A Roadmap for an Evidence-Based Answer. 
  • Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis. 
  • Does writing about the bereavement lessen grief following sudden, unintentional death? 
  • Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes. 
  • Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. 
  • Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. 
  • Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. 
  • Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. 
  • Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect. 
  • Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial. 
  • Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. 
  • Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform. 
  • Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases. 
  • Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation. 
  • Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. 
  • Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. 
  • Effect of new disability subtype on 3-year mortality in Chinese older adults. 
  • Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). 
  • Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study. 
  • Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction. 
  • Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. 
  • Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. 
  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. 
  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. 
  • Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial. 
  • Effects of prices, civil and criminal sanctions, and law enforcement on alcohol-related mortality. 
  • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. 
  • Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF. 
  • Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. 
  • Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. 
  • Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. 
  • Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013. 
  • Empirical Bayes procedures for stabilizing maps of U.S. cancer mortality rates. 
  • Employment characteristics and cause-specific mortality at automotive electronics manufacturing plants in Huntsville, Alabama. 
  • Epidemiology and outcomes of in-hospital cardiopulmonary resuscitation in the United States, 2000-2009. 
  • Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. 
  • Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. 
  • Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. 
  • Estimating increment-decrement life tables with multiple covariates from panel data: the case of active life expectancy. 
  • Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach. 
  • Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure. 
  • Evidence for a black-white crossover in all-cause and coronary heart disease mortality in an older population: the North Carolina EPESE. 
  • Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. 
  • Extracorporeal Membrane Oxygenation and Interfacility Transfer: A Regional Referral Experience. 
  • Extremely low birth weight and infant mortality rates in the United States. 
  • Facial fractures of the upper craniofacial skeleton predict mortality and occult intracranial injury after blunt trauma: an analysis. 
  • Failure to Rescue Rates After Coronary Artery Bypass Grafting: An Analysis From The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Failure to Rescue: A New Society of Thoracic Surgeons Quality Metric for Cardiac Surgery. 
  • Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality. 
  • Fatal police violence by race and state in the USA, 1980-2019: a network meta-regression. 
  • Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study. 
  • Follow-up study of chrysotile asbestos textile workers: cohort mortality and case-control analyses. 
  • Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. 
  • Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry. 
  • Frailty as an instrument for evaluation of elderly patients with non-ST-segment elevation myocardial infarction: A follow-up after more than 5 years. 
  • Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials. 
  • Fresh fruit consumption and all-cause and cause-specific mortality: findings from the China Kadoorie Biobank. 
  • Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. 
  • Function in elderly cancer survivors depends on comorbidities. 
  • Ganglioside GM1 in acute ischemic stroke. The SASS Trial. 
  • Gender differences in mortality after mitral valve operation: evidence for higher mortality in perimenopausal women. 
  • Gender differences in the cross-sectional and cohort age dependence of cause-specific mortality: the United States, 1962 to 1995. 
  • Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). 
  • Geographic Variations in Lung Cancer Lobectomy Outcomes: The General Thoracic Surgery Database. 
  • Geographic disparities in mortality from Alzheimer's disease and related dementias. 
  • Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. 
  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. 
  • Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. 
  • Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. 
  • Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 
  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. 
  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 
  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019. 
  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. 
  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Glycated Hemoglobin and All-Cause and Cause-Specific Mortality Among Adults With and Without Diabetes. 
  • Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. 
  • Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. 
  • Gunshot wounds: bullet caliber is increasing, 1998-2003. 
  • Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. 
  • Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data. 
  • Health Education and General Practitioner Training in Hypertension Management: Long-Term Effects on Kidney Function. 
  • Health at every size. 
  • Health differentials between blacks and whites: recent trends in mortality and morbidity. 
  • Health literacy interventions and outcomes: an updated systematic review. 
  • Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. 
  • Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. 
  • Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database. 
  • Hemiarch replacement at 28°C: an analysis of mild and moderate hypothermia in 500 patients. 
  • Heritability of death from respiratory diseases: an analysis of Danish twin survival data using a correlated frailty model. 
  • Heroic Measures for an American Hero: Attempting to Save the Life of General Douglas MacArthur. 
  • Heterogeneous Outcomes of Heart Failure with Better Ejection Fraction. 
  • High mortality rates for very low birth weight infants in developing countries despite training. 
  • High rates of AIDS-related mortality among older adults in rural Kenya. 
  • High-Density Lipoprotein Cholesterol and All-Cause and Cause-Specific Mortality Among the Elderly. 
  • High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort. 
  • Higher dietary diversity scores and protein-rich food consumption were associated with lower risk of all-cause mortality in the oldest old. 
  • Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. 
  • Hospital mortality of patients aged 80 and older after surgical repair for type A acute aortic dissection in Japan. 
  • Hostility as a predictor of survival in patients with coronary artery disease. 
  • Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries. 
  • Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA. 
  • Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. 
  • INTERMACS: interval analysis of registry data. 
  • Identifying a national death index match. 
  • IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. 
  • Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction. 
  • Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study. 
  • Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye Study (SiMES). 
  • Impact of a palliative care program on end-of-life care in a neonatal intensive care unit. 
  • Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). 
  • Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). 
  • Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. 
  • Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. 
  • Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy. 
  • Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. 
  • Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. 
  • Impact of radical prostatectomy in the management of clinically localized disease. 
  • Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. 
  • Implantable cardioverter defibrillators in Israel: utilization and implantation trends. 
  • Implantable cardioverter defibrillators: risks accompany the life-saving benefits. 
  • Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. 
  • Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. 
  • Improving ascertainment of sudden cardiac death in patients with end stage renal disease. 
  • Imputation of confidential data sets with spatial locations using disease mapping models. 
  • In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG. 
  • In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry. 
  • In-hospital death following inpatient surgical procedures in the United States, 1996-2006. 
  • In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial). 
  • Incidence of myocardial infarction, stroke, and death in patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor therapy. 
  • Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome. 
  • Increased Risk of Suicide Attempts and Unintended Death Among Those Transitioning From Prison to Community in Later Life. 
  • Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? 
  • Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure. 
  • Individual and center-level factors affecting mortality among extremely low birth weight infants. 
  • Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view. 
  • Infections in patients with cystic fibrosis following lung transplantation. 
  • Infectious complications of lung transplantation. 
  • Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. 
  • Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage. 
  • Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. 
  • Interaction Between the FOXO1A-209 Genotype and Tea Drinking Is Significantly Associated with Reduced Mortality at Advanced Ages. 
  • Interaction between digoxin and dronedarone in the PALLAS trial. 
  • International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS. 
  • Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis. 
  • Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. 
  • Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death. 
  • Investigation of accuracy of death certificate completion and implications on mortality statistics in Greece. 
  • Is birth order associated with adult mortality? 
  • Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial. 
  • Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis. 
  • Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up. 
  • Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. 
  • Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood. 
  • Leading Causes of Death among Asian American Subgroups (2003-2011). 
  • Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. 
  • Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. 
  • Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. 
  • Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. 
  • Liver transplantation at the University of Wisconsin. 
  • Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies. 
  • Long-Term Survival in Patients With Acute Kidney Injury After Acute Type A Aortic Dissection Repair. 
  • Long-term follow-up of unsuccessful violent suicide attempts: risk factors for subsequent attempts. 
  • Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor Study. 
  • Long-term impact of the Garrett Lee Smith Youth Suicide Prevention Program on youth suicide mortality, 2006-2015. 
  • Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis. 
  • Long-term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines-Heart Failure Registry. 
  • Long-term outcomes of mitral regurgitation by type and severity. 
  • Long-term results of liver transplantation in older patients 60 years of age and older. 
  • Long-term survival of veterans with traumatic spinal cord injury. 
  • Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. 
  • Longevity in the united states: age and sex-specific evidence on life span limits from mortality patterns 1960-1990. 
  • Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults : BMI change and the risks of colorectal cancer incidence and mortality. 
  • Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. 
  • Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. 
  • Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. 
  • Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. 
  • Management and long-term outcome of aortic dissection. 
  • Management of 239 patients with hypoplastic left heart syndrome and related malformations from 1993 to 2007. 
  • Management of abdominal aortic graft complications. 
  • Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. 
  • Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. 
  • Maternal near miss and mortality in a tertiary care hospital in Rwanda. 
  • Measuring the quality of dying in long-term care. 
  • Meconium aspiration syndrome: have we made a difference? 
  • Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. 
  • Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction. 
  • Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project. 
  • Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction. 
  • Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists. 
  • Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. 
  • Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome. 
  • Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. 
  • Meta-analysis: excess mortality after hip fracture among older women and men. 
  • Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030. 
  • Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. 
  • Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. 
  • Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes. 
  • Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. 
  • Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients. 
  • Moderate-to-Vigorous Physical Activity and All-Cause Mortality: Do Bouts Matter? 
  • Monocyte Count and 30-Day Case Fatality in Intracerebral Hemorrhage. 
  • Mortality among North Carolina construction workers, 1988-1994. 
  • Mortality among autoworkers manufacturing electronics in Huntsville, Alabama. 
  • Mortality among sheet metal workers participating in a respiratory screening program. 
  • Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy. 
  • Mortality and loss to follow-up among HAART initiators in rural South Africa. 
  • Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. 
  • Mortality in US Hemodialysis Patients Following Exposure to Wildfire Smoke. 
  • Mortality in elderly Canadians with and without dementia: a 5-year follow-up. 
  • Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). 
  • Mortality of older construction and craft workers employed at department of energy (DOE) nuclear sites: follow-up through 2011. 
  • Mortality patterns among female and male chrysotile asbestos textile workers. 
  • Mortality patterns in developed countries. 
  • Mortality rates in conflict zones in Karen, Karenni, and Mon states in eastern Burma. 
  • Mortality recovery and stabilization in Kazakhstan, 1995-2001. 
  • Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. 
  • Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. 
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. 
  • Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases. 
  • NIH funding trajectories and their correlations with US health dynamics from 1950 to 2004. 
  • Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. 
  • Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. 
  • Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. 
  • Newborn care training of midwives and neonatal and perinatal mortality rates in a developing country. 
  • Nocturia and associated mortality: observational data from the REDUCE trial. 
  • Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. 
  • Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. 
  • Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. 
  • Nondisease-specific problems and all-cause mortality in the REasons for Geographic and Racial Differences in Stroke study. 
  • Number of rib fractures thresholds independently predict worse outcomes in older patients with blunt trauma. 
  • Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. 
  • Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry. 
  • On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension. 
  • Opioid Overdose Deaths Among Formerly Incarcerated Persons and the General Population: North Carolina, 2000‒2018. 
  • Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. 
  • Organ Donation After Circulatory Death in Greece: Time to Consider. 
  • Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study. 
  • Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter. 
  • Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. 
  • Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Outdoor air pollution: a global perspective. 
  • Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT). 
  • Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. 
  • Patterns and trends in the cause of death for patients with endometrial cancer. 
  • Patterns of mortality and causes of death in polytrauma patients--has anything changed? 
  • Paving a Better Path for Patients Dying of Heart Disease. 
  • Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. 
  • Penetrating trauma in children on the United States-Mexico border: Hispanic ethnicity is not a risk factor. 
  • Perceived Discrimination and Cardiovascular Outcomes in Older African Americans: Insights From the Jackson Heart Study. 
  • Perceived social support as a predictor of mortality in coronary patients: effects of smoking, sedentary behavior, and depressive symptoms. 
  • Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? 
  • Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. 
  • Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. 
  • Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events. 
  • Personality facets and all-cause mortality among Medicare patients aged 66 to 102 years: a follow-on study of Weiss and Costa (2005). 
  • Phase II study of docetaxel in advanced soft tissue sarcomas. 
  • Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. 
  • Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. 
  • Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. 
  • Post-Traumatic Stress Disorder and Heart Failure in Men Within the Veteran Affairs Health System. 
  • Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. 
  • Postoperative short bowel syndrome. 
  • Postrelease mortality among persons hospitalized during their incarceration. 
  • Potential mediators of the mortality reduction with zoledronic acid after hip fracture. 
  • Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. 
  • Predialysis health, dialysis timing, and outcomes among older United States adults. 
  • Predicting mortality for paediatric inpatients where malaria is uncommon. 
  • Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors. 
  • Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease. 
  • Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. 
  • Predictors of mortality and morbidity in patients with chronic heart failure. 
  • Predictors of nonuse of donation after circulatory death lung allografts. 
  • Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. 
  • Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. 
  • Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. 
  • Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study. 
  • Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. 
  • Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. 
  • Preventability of pregnancy-related deaths: results of a state-wide review. 
  • Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer. 
  • Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis. 
  • Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. 
  • Processed electroencephalogram during donation after cardiac death. 
  • Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study. 
  • Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials. 
  • Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. 
  • Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. 
  • Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. 
  • Prognostic value of anxiety and depression in patients with chronic heart failure. 
  • Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. 
  • Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. 
  • Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation. 
  • Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). 
  • Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists. 
  • Promoting a good death for persons with dementia in nursing facilities: family caregivers' perspectives. 
  • Proportionate mortality among union members employed at three Texas refineries. 
  • Prospective study of externalizing and internalizing subtypes of posttraumatic stress disorder and their relationship to mortality among Vietnam veterans. 
  • Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors. 
  • Providing patient education: impact on quantity and quality of family health history collection. 
  • Psychiatry and Deaths of Despair. 
  • Psychosocial and behavioral predictors of longevity. The aging and death of the "termites". 
  • Psychosocial correlates of job strain in a sample of working women. 
  • Pulmonary Hypertension Subtypes and Mortality in CKD. 
  • Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair. 
  • Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. 
  • Quality Enhancement Research Initiative in stroke: prevention, treatment, and rehabilitation. 
  • Quality of life and long-term outcomes after hospitalization for COVID-19: Protocol for a prospective cohort study (Coalition VII). 
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. 
  • Race and Sex Differences in QRS Interval and Associated Outcome Among Patients with Left Ventricular Systolic Dysfunction. 
  • Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era. 
  • Racial differences in long-term outcomes among black and white patients with drug-eluting stents. 
  • Racial differences in mortality among patients with acute ischemic stroke: an observational study. 
  • Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes. 
  • Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. 
  • Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. 
  • Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). 
  • Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. 
  • Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial. 
  • Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital? 
  • Recent trends in US mortality in early and middle adulthood: racial/ethnic disparities in inter-cohort patterns. 
  • Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. 
  • Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. 
  • Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial). 
  • Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION). 
  • Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). 
  • Relation of Early Repolarization (J Point Elevation) to Mortality in Blacks (from the Jackson Heart Study). 
  • Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. 
  • Relation of lifetime trauma and depressive symptoms to mortality in HIV. 
  • Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention. 
  • Relationship between all-cause mortality and cumulative working life course psychosocial and physical exposures in the United States labor market from 1968 to 1992. 
  • Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION. 
  • Relationship between renal function and left ventricular assist device use. 
  • Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials. 
  • Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. 
  • Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction. 
  • Renal function, atherothrombosis extent, and outcomes in high-risk patients. 
  • Report from the Society of Thoracic Surgeons National Database Workforce: clarifying the definition of operative mortality. 
  • Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? 
  • Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. 
  • Resource use in the last 6 months of life among patients with heart failure in Canada. 
  • Rethinking the ross procedure in adults. 
  • Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. 
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • Revisiting the association of blood pressure with mortality in oldest old people in China: community based, longitudinal prospective study. 
  • Risk factors for conversion to cardiopulmonary bypass during off-pump coronary artery bypass surgery. 
  • Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. 
  • Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. 
  • Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. 
  • Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up. 
  • Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. 
  • Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. 
  • Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. 
  • Roles of mental health professionals in multidisciplinary medically supervised treatment programs for obesity. 
  • Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. 
  • Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. 
  • Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. 
  • Salvage radiation in men after prostate-specific antigen failure and the risk of death. 
  • Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. 
  • Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy. 
  • Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure. 
  • Sex and gender: modifiers of health, disease, and medicine. 
  • Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. 
  • Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease. 
  • Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS. 
  • Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. 
  • Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial). 
  • Sex-Related Differences in Heart Failure With Preserved Ejection Fraction. 
  • Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study. 
  • Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? 
  • Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. 
  • Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. 
  • Social dominance and 22-year all-cause mortality in men. 
  • Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. 
  • Stage IA non-small cell lung cancer: a small proportion of cases in the general population. 
  • Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. 
  • Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. 
  • Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer. 
  • Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). 
  • Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement. 
  • Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis. 
  • Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. 
  • Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF. 
  • Suicide in the elderly. 
  • Surgical portosystemic shunts for treatment of portal hypertensive bleeding: outcome and effect on liver function. 
  • Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. 
  • Surveillance issues in inflammatory bowel disease: ulcerative colitis. 
  • Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. 
  • Survival among Veterans Obtaining Dialysis in VA and Non-VA Settings. 
  • Survival among high-risk patients after bariatric surgery. 
  • Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health Administration. 
  • Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. 
  • Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. 
  • Survival of patients removed from the heart transplant waiting list. 
  • Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. 
  • Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. 
  • Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? 
  • Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial). 
  • The CHARM programme. 
  • The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries. 
  • The Effects of Climate Change on Cardiac Health. 
  • The FoxO3 gene and cause-specific mortality. 
  • The HIV-AIDS pandemic at 25--the global response. 
  • The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. 
  • The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations. 
  • The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study. 
  • The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer. 
  • The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy. 
  • The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. 
  • The STS AVR+CABG composite score: a report of the STS Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. 
  • The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. 
  • The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. 
  • The Society of Thoracic Surgeons 2021 Adult Cardiac Surgery Risk Models for Multiple Valve Operations. 
  • The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. 
  • The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. 
  • The association of depression and mortality in elderly persons: a case for multiple, independent pathways. 
  • The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database. 
  • The clinical course of pulmonary embolism. 
  • The complex relationship between center volume and outcome in patients undergoing the Norwood operation. 
  • The complex relationship between pediatric cardiac surgical case volumes and mortality rates in a national clinical database. 
  • The effect of community nurses and health volunteers on child mortality: the Navrongo Community Health and Family Planning Project. 
  • The effect of giving global coronary risk information to adults: a systematic review. 
  • The effect of legal drinking age on fatal injuries of adolescents and young adults. 
  • The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]. 
  • The effects of nutrition-related factors on four-year mortality among a biracial sample of community-dwelling elders in the North Carolina piedmont. 
  • The elder patient with suspected acute coronary syndromes in the emergency department. 
  • The emerging infrastructure of US firearms injury data. 
  • The epidemiology of drowning worldwide. 
  • The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. 
  • The heritability of cause-specific mortality: a correlated gamma-frailty model applied to mortality due to respiratory diseases in Danish twins born 1870-1930. 
  • The heritability of mortality due to heart diseases: a correlated frailty model applied to Danish twins. 
  • The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. 
  • The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. 
  • The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The prognostic role of body mass index on mortality amongst the middle-aged and elderly: a competing risk analysis. 
  • The role of cardiac morbidity in short- and long-term mortality in injured older patients who survive initial resuscitation. 
  • The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. 
  • Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. 
  • Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. 
  • Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. 
  • Time Trends and Educational Inequalities in Out-of-Hospital Coronary Deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) Project. 
  • Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials. 
  • Tobacco smoking and death from prostate cancer in US veterans. 
  • Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center. 
  • Topical tretinoin therapy and all-cause mortality. 
  • Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). 
  • Toward improved coronary artery revascularization: is this as good as it gets? 
  • Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. 
  • Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. 
  • Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). 
  • Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. 
  • Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. 
  • Trauma, comorbidity, and mortality following diagnoses of severe stress and adjustment disorders: a nationwide cohort study. 
  • Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. 
  • Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry). 
  • Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. 
  • Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. 
  • Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. 
  • Unexpected observations on tumor size and survival in stage IA non-small cell lung cancer. 
  • Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. 
  • Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. 
  • Unrelated umbilical cord blood transplantation in adult patients. 
  • Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. 
  • Use and 1-year outcomes with conventional and drug-coated balloon angioplasty in patients with lower extremity peripheral artery disease. 
  • Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. 
  • Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease. 
  • Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. 
  • Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. 
  • Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer. 
  • Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. 
  • Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry. 
  • Variation in ventilation time after coronary artery bypass grafting: an analysis from the society of thoracic surgeons adult cardiac surgery database. 
  • Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. 
  • Visual acuity and mortality in a chinese population. The Tanjong Pagar Study. 
  • Vitamin D and prostate cancer: a prediagnostic study with stored sera. 
  • Volume of Light Versus Moderate-to-Vigorous Physical Activity: Similar Benefits for All-Cause Mortality? 
  • WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database. 
  • Weighting composite endpoints in clinical trials: essential evidence for the heart team. 
  • What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program? 
  • Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. 
  • [Association between anemia and 3-year all-cause mortality among oldest old people in longevity areas in China]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Buckley, Rebecca Hatcher, James Buren Sidbury Distinguished Professor Emeritus of Pediatrics, in the School of Medicine, Pediatrics, Allergy and Immunology
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Dement, John McCray, Professor Emeritus in Family Medicine and Community Health, Family Medicine & Community Health,Occupational & Environmental Medicine
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Ostbye, Truls, Professor of Family Medicine and Community Health, Family Medicine and Community Health
  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine